Cargando…

GDNF-expressing macrophages mitigate loss of dopamine neurons and improve Parkinsonian symptoms in MitoPark mice

Glial cell line-derived neurotrophic factor (GDNF) is the most potent neuroprotective agent tested in cellular and animal models of Parkinson’s disease (PD). However, CNS delivery of GDNF is restricted by the blood-brain barrier (BBB). Using total body irradiation as transplant preconditioning, we p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Cang, Li, Xiuhua, Ge, Guo, Liu, Jingwei, Biju, K. C., Laing, Suzette D., Qian, Yusheng, Ballard, Cori, He, Zhixu, Masliah, Eliezer, Clark, Robert A., O’Connor, Jason C., Li, Senlin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882968/ https://www.ncbi.nlm.nih.gov/pubmed/29615705 http://dx.doi.org/10.1038/s41598-018-23795-4

Ejemplares similares

Multimodal MRI Evaluation of the MitoPark Mouse Model of Parkinson’s Disease
por: Cong, Linlin, et al.
Publicado: (2016)

Cognitive Dysfunction Precedes the Onset of Motor Symptoms in the MitoPark Mouse Model of Parkinson’s Disease
por: Li, Xiuhua, et al.
Publicado: (2013)

PTEN deletion enhances survival, neurite outgrowth and function of dopamine neuron grafts to MitoPark mice
por: Zhang, YaJun, et al.
Publicado: (2012)

Non-toxic HSC Transplantation-Based Macrophage/Microglia-Mediated GDNF Delivery for Parkinson’s Disease
por: Chen, Cang, et al.
Publicado: (2019)

Chronic L-DOPA induces hyperactivity, normalization of gait and dyskinetic behavior in MitoPark mice
por: Gellhaar, S, et al.
Publicado: (2015)

Chronic L‐DOPA induces hyperactivity, normalization of gait and dyskinetic behavior in MitoPark mice
Publicado: (2015)

Mechanisms of Sleep/Wake Regulation under Hypodopaminergic State: Insights from MitoPark Mouse Model of Parkinson's Disease
por: Fifel, Karim, et al.
Publicado: (2022)

Dopamine Neuron Stimulating Actions of a GDNF Propeptide
por: Bradley, Luke H., et al.
Publicado: (2010)

A Monoclonal Antibody-GDNF Fusion Protein Is Not Neuroprotective and Is Associated with Proliferative Pancreatic Lesions in Parkinsonian Monkeys
por: Ohshima-Hosoyama, Sachiko, et al.
Publicado: (2012)

Finding an Optimal Level of GDNF Overexpression: Insights from Dopamine Cycling
por: Marshall, Pepin
Publicado: (2023)

Dopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes
por: Indrieri, Alessia, et al.
Publicado: (2020)

Evidence for Sprouting of Dopamine and Serotonin Axons in the Pallidum of Parkinsonian Monkeys
por: Gagnon, Dave, et al.
Publicado: (2018)

Dopamine transporter SPECT imaging in Parkinson’s disease and parkinsonian disorders
por: AKDEMİR, Ümit Özgür, et al.
Publicado: (2021)

Review: Subjective Time Perception, Dopamine Signaling, and Parkinsonian Slowness
por: Miyawaki, Edison K.
Publicado: (2022)

Mouse Embryonic Stem Cells Expressing GDNF Show Enhanced Dopaminergic Differentiation and Promote Behavioral Recovery After Grafting in Parkinsonian Rats
por: Lara-Rodarte, Rolando, et al.
Publicado: (2021)

What Mechanisms Are Responsible for the Reuptake of Levodopa-Derived Dopamine in Parkinsonian Striatum?
por: Nishijima, Haruo, et al.
Publicado: (2016)

Blunt dopamine transmission due to decreased GDNF in the PFC evokes cognitive impairment in Parkinson’s disease
por: Tang, Chuan-Xi, et al.
Publicado: (2022)

Elevated endogenous GDNF induces altered dopamine signalling in mice and correlates with clinical severity in schizophrenia
por: Mätlik, Kärt, et al.
Publicado: (2022)

Loss of Nuclear Activity of the FBXO7 Protein in Patients with Parkinsonian-Pyramidal Syndrome (PARK15)
por: Zhao, Tianna, et al.
Publicado: (2011)

30-Month Results of Foetal Dopamine Cell Transplantation into the Brains of Parkinsonian Patients
por: Dymecki, J., et al.
Publicado: (1992)

Impairment of Macroautophagy in Dopamine Neurons Has Opposing Effects on Parkinsonian Pathology and Behavior
por: Hunn, Benjamin H.M., et al.
Publicado: (2019)

Rit2 silencing in dopamine neurons drives a progressive Parkinsonian phenotype
por: Kearney, Patrick J., et al.
Publicado: (2023)

Simultaneous Transplantation of Fetal Ventral Mesencephalic Tissue and Encapsulated Genetically Modified Cells Releasing GDNF in a Hemi-Parkinsonian Rat Model of Parkinson’s Disease
por: Perez-Bouza, Alberto, et al.
Publicado: (2017)

Pre- and Postsynaptic Dopamine SPECT in Idiopathic Parkinsonian Diseases: A Follow-Up Study
por: Jakobson Mo, Susanna, et al.
Publicado: (2013)

Neural correlates of standing imagery and execution in Parkinsonian patients: The relevance to striatal dopamine dysfunction
por: Mori, Yutaro, et al.
Publicado: (2020)

The network configuration in Parkinsonian state compensates network activity change caused by loss of dopamine
por: Kitano, Katsunori
Publicado: (2023)

MEF2C Enhances Dopaminergic Neuron Differentiation of Human Embryonic Stem Cells in a Parkinsonian Rat Model
por: Cho, Eun-Gyung, et al.
Publicado: (2011)

The impact of a parkinsonian lesion on dynamic striatal dopamine transmission depends on nicotinic receptor activation
por: Jennings, Katie A., et al.
Publicado: (2015)

Transplantation site influences the phenotypic differentiation of dopamine neurons in ventral mesencephalic grafts in Parkinsonian rats
por: Fjodorova, Marija, et al.
Publicado: (2017)

Cryopreservation Maintains Functionality of Human iPSC Dopamine Neurons and Rescues Parkinsonian Phenotypes In Vivo
por: Wakeman, Dustin R., et al.
Publicado: (2017)

Impaired reach-to-grasp kinematics in parkinsonian patients relates to dopamine-dependent, subthalamic beta bursts
por: Vissani, Matteo, et al.
Publicado: (2021)

Correlations between cerebrospinal fluid homovanillic acid and dopamine transporter SPECT in degenerative parkinsonian syndromes
por: Goto, Ryoji, et al.
Publicado: (2023)

The Future of GDNF in Parkinson's Disease
por: Manfredsson, Fredric P., et al.
Publicado: (2020)

Photoreceptor preservation induced by intravitreal controlled delivery of GDNF and GDNF/melatonin in rhodopsin knockout mice
por: García-Caballero, Cristina, et al.
Publicado: (2018)

Dopamine Transporter Imaging in Parkinson Disease: Progressive Changes and Therapeutic Modification after Anti-parkinsonian Medications
por: Ikeda, Ken, et al.
Publicado: (2019)

Sleep deprivation disrupts striatal anti-apoptotic responses in 6-hydroxy dopamine-lesioned parkinsonian rats
por: Ahmadian, Nahid, et al.
Publicado: (2018)

Pilot Study for Correlation of Heart Rate Variability and Dopamine Transporter Brain Imaging in Patients with Parkinsonian Syndrome
por: Warhadpande, Devdutta S., et al.
Publicado: (2022)

No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome
por: Schiebler, Tassilo, et al.
Publicado: (2023)

The GDNF Family: A Role in Cancer?
por: Fielder, Graeme C., et al.
Publicado: (2017)

GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson’s disease
por: d’Anglemont de Tassigny, Xavier, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cef654ipvimuh7t1g615848flm